Participants 15 167 7
responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender
Participants 203 364 3
to study the individual responsiveness to GH treatment in terms of body composition and to search for possible predictors of the response in GH-deficient adults.
Participants 365 682 9
Sixty-eight patients (44 men and 24 women) with a mean age of 44.3 (1.2) yr and verified GH deficiency participated in a 2-phase treatment trial with an initial randomized, double blind, placebo-controlled, 6-month period, followed by an open treatment period, thereby ensuring all patients 12 months of GH treatment.
Participants 1648 1684 3
TBW was greater in men than in women
